Biotech Buzz – The 3 Must-Know Headlines of the Month
Don’t let the latest biotech news catch you by surprise!
Hey, biotech buffs! You won’t want to miss this month’s Biotech Buzz section, where we’re bringing you the three most exciting headlines in the industry right now:
- “New Gene Therapy Shows Promise in Treating Rare Genetic Disorders.”
- “CRISPR Gene Editing Technology Advances Could Revolutionize Drug Development.”
- “FDA Approves First Oral Medication for Treatment of Multiple Sclerosis.”
Want to stay in the know when it comes to biotech?
Boost Your FP&A Efficiency: 20 Excel Hacks You Need to Know In this month’s Financial Fitness section, we’re sharing some of the best practices and insights when it comes to financial planning and analysis (FP&A) to help you master your finances and stay on top.
Funding Data for Biotech Companies in Q1 2023
Calling all CFOs!
In this month’s CFO Insider section, we’re giving you insights on the Funding of Biotech Companies in 1st Quarter of 2023
The biotech industry continues to be a HOTBED of innovation and investment, with many companies making significant progress in developing new therapies and treatments. In Q1 2023, biotech companies raised a total of $15.2 billion in funding, up 27% from the same period last year. Here are some of the key trends and insights from the latest funding data.
Supply Chain Spotlight
Ready to take on the world?
Our Supply Chain Spotlight section reveals emerging markets’ most extensive opportunities, challenges & Insights, so you can expand your horizons and dominate your supply chain game.
In this month’s Supply Chain Spotlight, we’re taking a closer look at Emerging Markets and Their Impact on Global Supply Chains.